ONCT - Oncternal Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

ONCT is currently covered by 5 analysts with an average price target of $9.91. This is a potential upside of $1.36 (15.91%) from yesterday's end of day stock price of $8.55.

Oncternal Therapeutics's activity chart (see below) currently has 0 price targets and 14 ratings on display. The stock rating distribution of ONCT is 64.29% BUY and 35.71% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48% with an average time for these price targets to be met of 150 days.

Highest price target for ONCT is $28, Lowest price target is $1.3, average price target is $9.91.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 15-Apr-2024. First documented stock forecast 10-May-2022.

Best performing analysts who are covering ONCT - Oncternal Therapeutics:

Raghuram Selvaraju Hartaj Singh Li Watsek Naureen Quibria Kemp Dolliver

Currently out of the existing stock ratings of ONCT, 9 are a BUY (64.29%), 5 are a HOLD (35.71%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

28

$19.45 (227.49%)

30

9 days ago

2/5 (40%)

$19.2 (218.18%)

129

Buy

2

$-6.55 (-76.61%)

4 months 20 days ago

0/1 (0%)

$-5 (-71.43%)

Hold

1.3

$-7.25 (-84.80%)

4

7 months 17 days ago

0/3 (0%)

$-4.7 (-78.33%)

Hold

9

1 years 20 days ago

1/1 (100%)

$-5.2 (-36.62%)

13

Hold

3.5

1 years 21 days ago

1/1 (100%)

$2.5 (250.00%)

608

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCT (Oncternal Therapeutics) average time for price targets to be met?

On average it took 150 days on average for the stock forecasts to be realized with a an average price target met ratio 48

Which analyst has the current highest performing score on ONCT (Oncternal Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on ONCT (Oncternal Therapeutics) with a proven track record?

KEMP DOLLIVER

Which analyst has the most public recommendations on ONCT (Oncternal Therapeutics)?

Raghuram Selvaraju has 16 price targets and 15 ratings on ONCT

Which analyst is the currently most bullish on ONCT (Oncternal Therapeutics)?

Raghuram Selvaraju with highest potential upside - $19.45

Which analyst is the currently most reserved on ONCT (Oncternal Therapeutics)?

Li Watsek with lowest potential downside - -$7.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?